Pulmonary Vascular Disease in Chronic Obstructive Pulmonary Disease.

IF 2.3 3区医学 Q2 CRITICAL CARE MEDICINE

Seminars in respiratory and critical care medicine Pub Date : 2024-10-01 Epub Date: 2024-11-12 DOI:10.1055/s-0044-1791824

Dana Kay, Roberto Bernardo, Jean Elwing

引用次数: 0

Abstract

Pulmonary hypertension (PH) is a vascular disease characterized by pulmonary artery remodeling and right heart failure. PH related to COPD is a precapillary form of the disease, with hemodynamic measurements including a mean pulmonary artery pressure of greater than 20 mm Hg, a wedge pressure of less than 15 mm Hg, and a pulmonary vascular resistance of greater than 3 WU (Woods units), categorized under the World Health Organization classification as group 3. The presence of PH in COPD has been known to increase morbidity and mortality. Limited studies have evaluated treatment options for PH related to COPD.

查看原文本刊更多论文

慢性阻塞性肺病中的肺血管疾病。

肺动脉高压（PH）是一种以肺动脉重塑和右心衰竭为特征的血管疾病。与慢性阻塞性肺疾病相关的肺动脉高压是一种毛细血管前疾病，其血液动力学测量值包括平均肺动脉压大于 20 毫米汞柱、楔压小于 15 毫米汞柱、肺血管阻力大于 3 WU（伍兹单位），根据世界卫生组织的分类，属于第 3 组。对慢性阻塞性肺病相关 PH 治疗方案的评估研究有限。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Seminars in respiratory and critical care medicine 医学-呼吸系统

CiteScore

6.10

自引率

0.00%

发文量

审稿时长

6-12 weeks

期刊介绍： The journal focuses on new diagnostic and therapeutic procedures, laboratory studies, genetic breakthroughs, pathology, clinical features and management as related to such areas as asthma and other lung diseases, critical care management, cystic fibrosis, lung and heart transplantation, pulmonary pathogens, and pleural disease as well as many other related disorders.The journal focuses on new diagnostic and therapeutic procedures, laboratory studies, genetic breakthroughs, pathology, clinical features and management as related to such areas as asthma and other lung diseases, critical care management, cystic fibrosis, lung and heart transplantation, pulmonary pathogens, and pleural disease as well as many other related disorders.